The Effect of the &agr;2-Agonist Dexmedetomidine and the N-Methyl-d-Aspartate Antagonist S(+)-Ketamine on the Expression of Apoptosis-Regulating Proteins After Incomplete Cerebral Ischemia and Reperfusion in Rats

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Anesthesia and Analgesia

• Publication date

  2003-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1213/00000539-200302000-00041PMID 12538207
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neurons Are Protected from Excitotoxic Death by p53 Antisense Oligonucleotides Delivered in Anionic Liposomes*

  2001cited by this paper
• Detection of high molecular weight DNA fragments characteristic of early stage apoptosis in cerebellar granule cells exposed to glutamate

  2000cited by this paper
• High-dose S(+)- ketamine improves neurological outcome following incomplete cerebral ischemia in rats

  2000cited by this paper
• BCL-2 transduction, using a herpes simplex virus amplicon, protects hippocampal neurons from transient global ischemia.

  1999cited by this paper
• The tumor-suppressor gene, p53, is induced in injured brain regions following experimental traumatic brain injury.

  1999cited by this paper
• Potentiation of murine astrocyte antioxidant defence by bcl‐2: protection in part reflects elevated glutathione levels

  1998cited by this paper
• Bcl-x(l) Bax interaction after transient global ischemia.

  1998cited by this paper
• Monoamine-Induced Apoptotic Neuronal Cell Death

  1997cited by this paper
• Apoptosis and protein expression after focal cerebral ischemia in rat.

  1997cited by this paper
• p53‐Knockout Mice Are Protected Against the Long‐Term Effects of Methamphetamine on Dopaminergic Terminals and Cell Bodies

  1997cited by this paper
• Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked

  1997cited by this paper
• The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis

  1997cited by this paper
• Bcl-2 inhibits the mitochondrial release of an apoptogenic protease

  1996cited by this paper
• BAX-induced cell death may not require interleukin 1 beta-converting enzyme-like proteases.

  1996cited by this paper
• Altered expression of Bcl-2, Bcl-X, Bax, and c-Fos colocalizes with DNA fragmentation and ischemic cell damage following middle cerebral artery occlusion in rats.

  1996cited by this paper
• Stimulation of N-methyl-D-aspartate receptors induces apoptosis in rat brain.

  1996cited by this paper
• Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo.

  1994cited by this paper
• Immediate early up-regulation of bax expression by p53 but not TGF beta 1: a paradigm for distinct apoptotic pathways.

  1994cited by this paper
• Interaction of catecholamines and nitrous oxide ventilation during incomplete brain ischemia in rats.

  1993cited by this paper
• Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death.

  1993cited by this paper
• Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

  1993cited by this paper
• The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

  1992cited by this paper
• Dexmedetomidine improves neurologic outcome from incomplete ischemia in the rat. Reversal by the alpha 2-adrenergic antagonist atipamezole.

  1991cited by this paper
• Neurologic Outcome in Rats Following Incomplete Cerebral Ischemia during Halothane, Isoflurane, or N2O

  1988cited by this paper
• The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining.

  1985cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• Dexmedetomidine Mitigates Sevoflurane-Induced Neurodevelopmental Effects in Paediatric Anaesthesia: A Meta-Analysis and Preclinical Study

  2026cites this paper
• MDM2 in the signaling pathways related to neurological diseases.

  2025cites this paper
• Dexmedetomidine pretreatment improves postsurgical delay in neurocognitive recovery in aged mice by inhibiting hippocampal microglial activation via activation of cholinergic anti-inflammatory pathways

  2025cites this paper
• Ecotoxicological risk assessment of the novel psychoactive substance Esketamine: Emphasis on fish skeletal, behavioral, and vascular development.

  2024cites this paper
• The influencer effect of Dexmedetomidine on radioiodine relevant to lacrimal gland impairment

  2024cites this paper
• Alleviation effects of dexmedetomidine on myocardial ischemia/reperfusion injury through fatty acid metabolism pathway via Elovl6.

  2024cites this paper
• Pre-clinical and clinical trials for anesthesia in neonates: gaps and future directions

  2024cites this paper
• Post Cardiac Arrest Care in the Cardiac Intensive Care Unit

  2024cites this paper
• The role of anesthesia in peri‑operative neurocognitive disorders: Molecular mechanisms and preventive strategies

  2023cites this paper
• Stroke and translational research - review of experimental models with a focus on awake ischaemic induction and anaesthesia.

  2023cites this paper
• Apoptotic mechanism of development inhibition in zebrafish induced by esketamine.

  2023cites this paper
• A retrospect and outlook on the neuroprotective effects of anesthetics in the era of endovascular therapy

  2023cites this paper
• Multiple uses of dexmedetomidine in small animals: a mini review

  2023cites this paper
• Propofol and α2-Agonists Attenuate Microglia Activation and Restore Mitochondrial Function in an In Vitro Model of Microglia Hypoxia/Reoxygenation

  2022cites this paper
• Neurotoxic Impact of Individual Anesthetic Agents on the Developing Brain

  2022cites this paper
• The use of ketamine as a neuroprotective agent following cardiac arrest: A scoping review of current literature

  2022cites this paper
• Dexmedetomidine Inhibits NF-κB-Transcriptional Activity in Neurons Undergoing Ischemia-Reperfusion by Regulating O-GlcNAcylation of SNW1.

  2022cites this paper
• La respuesta inmunológica al neurotrauma: implicaciones en anestesiología

  2022cites this paper
• Dexmedetomidine Confers Protection Against Neuronal Oxygen Glucose Deprivation-Reperfusion by Regulating SIRT3 Mediated Autophagy

  2022cites this paper
• Prophylactic Effects of Sub-anesthesia Ketamine on Cognitive Decline, Neuroinflammation, and Oxidative Stress in Elderly Mice

  2022cites this paper
• Dexmedetomidine Attenuates Spinal Cord Ischemia-reperfusion Injury in Rabbits by Decreasing Oxidation and Apoptosis.

  2022cites this paper
• Reducing Benzodiazepine Exposure by Instituting a Guideline for Dexmedetomidine Usage in the NICU

  2021cites this paper
• Protective effects of dexmedetomidine on ischaemia‐reperfusion injury in an experimental rat model of priapism

  2021cites this paper
• Dexmedetomidine facilitates the expression of nNOS in the hippocampus to alleviate surgery-induced neuroinflammation and cognitive dysfunction in aged rats

  2021cites this paper
• Increased Risk of Transient Cerebral Ischemia Following Subarachnoid Hemorrhage in Patients with Premorbid Opioid Use Disorders: A Nationwide Analysis of Outcomes.

  2020cites this paper
• Protective effects of dexmedetomidine on small intestinal ischaemia-reperfusion injury in horses.

  2020cites this paper
• The Protective Effects of Dexmedetomidine Preconditioning on Hepatic Ischemia/Reperfusion Injury in Rats.

  2020cites this paper
• Dexmedetomidine for sedation in intensive care. Literature review and clinical experience

  2020cites this paper
• Dexmedetomidine Resists Intestinal Ischemia-Reperfusion Injury by Inhibiting TLR4/MyD88/NF-κB Signaling.

  2020cites this paper
• Evaluation of the effects of dexmedetomidine on liver damage secondary to renal ischemia-reperfusion

  2020cites this paper
• Hepatic Protective Effect of Dexmedetomidine after Partial Hepatectomy Surgery: A Prospective Controlled Study

  2019cites this paper
• Effects of Dexmedetomidine on Myocardial Repolarization in Children Undergoing General Anesthesia: A Randomized Controlled Trial.

  2019cites this paper
• A systematic review and narrative synthesis on the histological and neurobehavioral long‐term effects of dexmedetomidine

  2019cites this paper
• Effects of Dexmedetomidine on Blood Glucose and Serum Potassium Levels in Children Undergoing General Anesthesia: A Secondary Analysis of Safety Endpoints During a Randomized Controlled Trial.

  2019cites this paper
• Irisin Contributes to the Hepatoprotection of Dexmedetomidine during Intestinal Ischemia/Reperfusion

  2019cites this paper
• Dexmedetomidine attenuates the induction and reverses the progress of 6-hydroxydopamine- induced parkinsonism; involvement of KATP channels, alpha 2 adrenoceptors and anti-inflammatory mechanisms.

  2019cites this paper
• Optimization and Validation of the Spectrophotometric Methods for the Assay of Dexmedetomidine Hydrochloride in Pure and Dosage Forms

  2019cites this paper
• Dexmedetomidine restores autophagy and cardiac dysfunction in rats with streptozotocin-induced diabetes mellitus

  2018cites this paper
• Pediatric ECMO after drowning: Neuroprotective strategies

  2018cites this paper
• Effect of acupuncture on expression levels of NF-κB , IL-1 β , IL-6 , and TNF-α in rats with cerebral ischemia and reperfusion

  2018cites this paper
• MicroRNA‐140‐5p elevates cerebral protection of dexmedetomidine against hypoxic–ischaemic brain damage via the Wnt/β‐catenin signalling pathway

  2018cites this paper
• Anesthesia-Associated Relative Hypovolemia: Mechanisms, Monitoring, and Treatment Considerations

  2018cites this paper
• The Ameliorative Potential of Dexmedetomidine and Benincasa Cerifera Extract in Renal Ischemia/Reperfusion Injury in a Streptozotocin-Induced Diabetic Model

  2018cites this paper
• CLINICAL EFFICACY OF DEXMEDETOMIDINE IN PATIENTS OF MOYAMOYA DISEASE UNDERGOING EDAS PROCEDURE- A RETROSPECTIVE ANALYSIS FROM INDIAN TERTIARY INSTITUTE

  2018cites this paper
• Effect of dexmedetomidine on the development of mechanical allodynia and central sensitization in chronic post-ischemia pain rats

  2018cites this paper
• Dexmedetomidine alleviates cerebral ischemia‐reperfusion injury in rats via inhibition of hypoxia‐inducible factor‐1α

  2018cites this paper
• Dexmedetomidine protects against myocardial ischaemia/reperfusion-induced renal damage in rats

  2018cites this paper
• Dexmedetomidine attenuates the propofol-induced long-term neurotoxicity in the developing brain of rats by enhancing the PI3K/Akt signaling pathway

  2018cites this paper
• Dexmedetomidine: A Solution to the Dilemma of Pain and Agitation in the Mechanically Ventilated Preterm Neonate?

  2017cites this paper
• Dexmedetomidine Oral Mucosa Patch for Sedation Suppresses Apoptosis in Hippocampus of Normal Rats

  2017cites this paper
• Effects of dexmedetomidine on renal tissue after lower limb ischemia reperfusion injury in streptozotocin induced diabetic rats

  2017cites this paper
• Neuroprotection and neurotoxicity in the developing brain: an update on the effects of dexmedetomidine and xenon.

  2017cites this paper
• Effect of Single Compared to Repeated Doses of Intravenous S(+) Ketamine on the Release of Pro-inflammatory Cytokines in Patients Undergoing Radical Prostatectomy

  2017cites this paper
• Clinical Pharmacokinetics and Pharmacodynamics of Dexmedetomidine

  2017cites this paper
• [Effect of dexmedetomidine on acute lung injury in experimental ischemia-reperfusion model].

  2017cites this paper
• Efeito de dexmedetomidina sobre lesão pulmonar aguda em modelo experimental de isquemia‐reperfusão

  2017cites this paper
• Dexmedetomidine inhibits activation of the MAPK pathway and protects PC12 and NG108-15 cells from lidocaine-induced cytotoxicity at its maximum safe dose.

  2017cites this paper
• Neurodegenerative changes and neuroapoptosis induced by systemic lipopolysaccharide administration are reversed by dexmedetomidine treatment in mice

  2017cites this paper
• Protective effects of dexmedetomidine and remote ischemic preconditioning on renal ischemia reperfusion injury in rats.

  2017cites this paper
• Les effets du fentanyl sur la douleur et la motricité suite à une hémorragie intracérébrale induite chez le rat

  2017cites this paper
• Dexmedetomidine Protects Mouse Brain from Ischemia-Reperfusion Injury via Inhibiting Neuronal Autophagy through Up-Regulating HIF-1α

  2017cites this paper
• Pharmacologic Considerations of Anesthetic Agents in Geriatric Patients.

  2017cites this paper
• Dexmedetomidine confers neuroprotection against transient global cerebral ischemia/reperfusion injury in rats by inhibiting inflammation through inactivation of the TLR-4/NF-κB pathway.

  2017cites this paper
• Dexmedetomidine Attenuates Lipopolysaccharide Induced MCP-1 Expression in Primary Astrocyte

  2017cites this paper
• Does remifentanil attenuate renal ischemia–reperfusion injury better than dexmedetomidine in rat kidney?

  2017cites this paper
• Dexmedetomidine Combined with Therapeutic Hypothermia Is Associated with Cardiovascular Instability and Neurotoxicity in a Piglet Model of Perinatal Asphyxia

  2017cites this paper
• Use of Dexmedetomidine in Cardiothoracic and Vascular Anesthesia.

  2017cites this paper
• [Histopathologic comparison of dexmedetomidine's and thiopental's cerebral protective effects on focal cerebral ischemia in rats].

  2016cites this paper
• Intraoperative dexmedetomidine and postoperative cerebral hyperperfusion syndrome in patients who underwent superficial temporal artery-middle cerebral artery anastomosis for moyamoya disease

  2016cites this paper
• Dexmedetomidine ameliorates lipopolysaccharide-induced endothelial barrier disruption and inflammation by inhibiting NF-κB activity and activating α 2-adrenergic receptor

  2016cites this paper
• Dexmedetomidine Acts via the JAK2/STAT3 Pathway to Attenuate Isoflurane-Induced Neurocognitive Deficits in Senile Mice

  2016cites this paper
• The effects of dexmedetomidine on renal injury induced by intra-abdominal hypertension in rats

  2016cites this paper
• EXPERIMENTAL MODEL OF TRAUMATIC SPINAL CORD INJURY AND NEUROPROTECTIVE EFFECT OF KETAMINE IN ACUTE PHASE OF INJURY

  2016cites this paper
• The Effects of Ketamine on Cognitive Function in Elderly Patients Undergoing Ophthalmic Surgery: A Pilot Study

  2016cites this paper
• Dexmedetomidine protects the heart against ischemia-reperfusion injury by an eNOS / NO / PKG dependent mechanism

  2016cites this paper
• Protective effects of udenafil citrate, piracetam and dexmedetomidine treatment on testicular torsion/detorsion‐induced ischaemia/reperfusion injury in rats

  2016cites this paper
• Dexmedetomidine preconditioning inhibits the long term inflammation induced by renal ischemia/reperfusion injury in rats.

  2016cites this paper
• Effects of fentanyl on pain and motor behaviors following a collagenase-induced intracerebral hemorrhage in rats

  2016cites this paper
• Protective role of dexmedetomidine in unmethylated CpG-induced inflammation responses in BV2 microglia cells.

  2016cites this paper
• Dexmedetomidine protects the heart against ischemia-reperfusion injury by an endothelial eNOS/NO dependent mechanism.

  2016cites this paper
• A forecast of relevant pediatric sedation trends

  2016cites this paper
• Effect of dexmedetomidine on hepatic ischemia–reperfusion injury in the setting of adult living donor liver transplantation

  2016cites this paper
• Dexmedetomidine alleviates cerebral ischemia-induced short-term memory impairment by inhibiting the expression of apoptosis-related molecules in the hippocampus of gerbils

  2016cites this paper
• Dexmedetomidine Protects against Transient Global Cerebral Ischemia/Reperfusion Induced Oxidative Stress and Inflammation in Diabetic Rats

  2016cites this paper
• Dexmedetomidine attenuates repeated propofol exposure-induced hippocampal apoptosis, PI3K/Akt/Gsk-3β signaling disruption, and juvenile cognitive deficits in neonatal rats

  2016cites this paper
• Curcumin and dexmedetomidine prevents oxidative stress and renal injury in hind limb ischemia/reperfusion injury in a rat model

  2016cites this paper
• Treadmill exercise ameliorates intracerebral hemorrhage-induced depression in rats

  2016cites this paper
• Efficacy and Acceptability of Different Auxiliary Drugs in Pediatric Sevoflurane Anesthesia: A Network Meta-analysis of Mixed Treatment Comparisons

  2016cites this paper
• Anesthesia in Experimental Stroke Research

  2016cites this paper
• Tanshinone IIA Affects Autophagy and Apoptosis of Glioma Cells by Inhibiting Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Pathway

  2016cites this paper
• Dexmedetomidine ameliorates acute lung injury following orthotopic autologous liver transplantation in rats probably by inhibiting Toll-like receptor 4–nuclear factor kappa B signaling

  2015cites this paper
• Bradycardia in perspective—not all reductions in heart rate need immediate intervention

  2015cites this paper
• Dexmedetomidine Directly Increases Tau Phosphorylation

  2015cites this paper
• Alpha-2 agonist attenuates ischemic injury in spinal cord neurons.

  2015cites this paper
• Dexmedetomidine improves early postoperative cognitive dysfunction in aged mice.

  2015cites this paper
• [Rectal dexmedetomidine in rats: evaluation of sedative and mucosal effects].

  2015cites this paper
• The effect of Intravenous Ketamine during Cardiopulmonary Bypass on Postoperative Agitation

  2015cites this paper
• La dexmedetomidina rectal en ratones: evaluación de los efectos sedativos y sobre la mucosa

  2015cites this paper
• Dexmedetomidine protects from post-myocardial ischaemia reperfusion lung damage in diabetic rats

  2015cites this paper
• Dexmedetomidine protects against apoptosis induced by hypoxia/reoxygenation through the inhibition of gap junctions in NRK-52E cells.

  2015cites this paper